Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 Immunotherapy

These data demonstrate that CD8⁺ T cells contribute to tumor control even in the absence of direct antigen presentation by tumor cells. More broadly, our work suggests that strategies to activate the effector functions of inflammatory monocytes may limit tumor growth and overcome acquired resistance to immune checkpoint inhibitors.